Skip to content

Comparison of immunotherapy with aeroallergens and drug treatment in patients with allergic rhinitis

Comparison of immunotherapy with aeroallergens and drug treatment in patients with allergic rhinitis

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20171030037093N15
Enrollment
120
Registered
2019-07-11
Start date
2019-07-23
Completion date
Unknown
Last updated
2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic rhinitis. Allergic rhinitis, unspecified

Interventions

Intervention 1: Intervention group: Patients received the usual drug treatment, including inhaled glucocorticoids (Fluticasone) and antihistamines once a day for one month. Intervention 2: Interventio

Sponsors

Shahre-kord University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to 50 Years

Inclusion criteria

Inclusion criteria: Age 10 and over 10 years Age less than 50 years Lack of advanced and severe asthma Negative pregnancy test for women Lack of autoimmune disease Lack of immunodeficiency disease Lack of malignancy

Exclusion criteria

Exclusion criteria: Patient lack of cooperation Continuous use of immunosuppressive drugs Continuous use of antihistamines Taking beta-blocker medications History of allergy to each of the treatment groups

Design outcomes

Primary

MeasureTime frame
Sneeze. Timepoint: Before intervention, 2 years after intervention. Method of measurement: Checklist containing clinical symptoms.;Cough. Timepoint: Before intervention, 2 years after intervention. Method of measurement: Checklist containing clinical symptoms.;Rhinorrhea. Timepoint: Before intervention, 2 years after intervention. Method of measurement: Checklist containing clinical symptoms.;Itchy eyes. Timepoint: Before intervention, 2 years after intervention. Method of measurement: Checklist containing clinical symptoms.;Itchy throat. Timepoint: Before intervention, 2 years after intervention. Method of measurement: Checklist containing clinical symptoms.;Post nasal discharge. Timepoint: Before intervention, 2 years after intervention. Method of measurement: Checklist containing clinical symptoms.;Nasal congestion. Timepoint: Before intervention, 2 years after intervention. Method of measurement: Checklist containing clinical symptoms.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Ali Zamani

Shahre-kord University of Medical Sciences

zamani.m@skums.ac.ir+98 38 3334 2414

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026